New York, June 5, 2026, 06:02 (EDT)
Health In Tech Inc. shares edged up in Friday premarket, with the Nasdaq stock closing Thursday at $1.0000, a 3.63% gain. The stock was quoted at $1.0300 after hours at 6:56 p.m. EDT, according to Yahoo Finance data.
Stocks are trading as usual. Nasdaq keeps its regular hours, opening at 9:30 a.m. and closing at 4:00 p.m. Eastern, and lists premarket trading from 4:00 a.m. The 2026 holiday calendar shows the next market closure is June 19 for Juneteenth.
Health In Tech is working to keep investors interested as the market backdrop shifts ahead of the open. U.S. tech futures dropped Friday with traders watching chip stocks slip and looking ahead to the U.S. jobs data. On Thursday, trading had favored banks, small caps and some healthcare stocks.
Healthcare stocks got a boost, but it wasn’t the same play. UnitedHealth, CVS and Humana all jumped Thursday as analysts flagged improving medical-cost trends for managed-care names—insurers that keep costs down through networks and care programs. Health In Tech, though, is smaller and more behind-the-scenes in insurance.
Health In Tech calls itself an AI-driven insurtech platform working in the self-funded health insurance space. It says it provides tech for brokers, carriers, managing general underwriters, and third-party administrators. The company focuses on self-funded employer health plans, where the employer holds most of the claims risk and usually buys stop-loss insurance to cap large losses.
Health In Tech Inc. reported first-quarter revenue up 9.4% to $8.8 million, but posted a net loss of $1.6 million after showing net income the previous year. Adjusted EBITDA dropped into the red, falling to negative $1.3 million from positive $1.2 million.
Tim Johnson, chief executive, said 2026 will be “a year of investing for growth.” He said new stop-loss products and a three-year rate stabilization plan are set to bring “meaningful revenue” later in the year. The company kept its full-year revenue outlook at $45 million to $50 million. PR Newswire
On the earnings call, Johnson described the self-funded stop-loss market as “massive, opaque” and said broker penetration at Health In Tech remains “well below one-tenth of 1%.” That line sums up the bull thesis: Health In Tech is a small player looking to expand tools across a big broker channel. TradingView
BofA analysts, led by Kevin Fischbeck, said Thursday “improving medical cost trends” offer an “attractive risk/reward” for UnitedHealth. They suggested a moderation in utilization could drive a rally in managed-care stocks. This doesn’t impact Health In Tech’s earnings, but could help boost investor interest in insurance-linked names. Barchart
But there’s another part to the trade. A May 22 amended S-3 filing covers plans for selling stockholders to resell up to 5.6 million Class A shares. Health In Tech said it won’t get any proceeds from these stockholder sales. The filing also warned that either the sales, or even talk of them, might push the share price lower.
Friday’s action looks straightforward. Bulls want proof the market trusts management’s second-half revenue targets. Bears point to wider losses, negative adjusted EBITDA, and more resale supply possibly weighing on a stock stuck near $1.
